Back to Search
Start Over
Supplementary Data from Phase I Trial of Expanded, Activated Autologous NK-cell Infusions with Trastuzumab in Patients with HER2-positive Cancers
Details
- Database :
- OpenAIRE
- Accession number :
- edsair.doi.dedup.....a0209f96b4c5f79fd3d29bd1e4c30823